Several clinical trials have demonstrated the relative tolerability of losartan. [8,14,18,19,20] The most frequent adverse reaction, as observed in a clinical trial of 2900 patients assessing the ...
Merck & Co's new angiotensin II inhibitor Cozaar (losartan potassium) has been approved by the US Food and Drug Administration for the management of patients with hypertension. Merck will position the ...